Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial - The Lancet Neurology

Description

Early Experience With Tenecteplase at a Comprehensive Stroke Center

Different dosing regimens of Tenecteplase in acute ischemic stroke: A network meta-analysis of the clinical evidence - Ei Zune The, Ne Naing Lin, Mazen Matar, Hock Luen Teoh, Leonard Leong Litt Yeo

Frontiers Tenecteplase Thrombolysis in Posterior Circulation Stroke

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR- TEST): a phase 3, randomised, open-label, blinded endpoint trial - The Lancet Neurology

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

PDF] Tenecteplase versus alteplase ( TENVALT ) : A study comparing two thrombolytic agents in acute ischemic stroke

Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial - The Lancet

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

PDF] Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials

Advances in Acute Ischemic Stroke Therapy

Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

PDF] Tenecteplase versus Alteplase for the Management of Acute Ischemic Stroke in a Low-income Country–Nepal: Cost, Efficacy, and Safety

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial - The Lancet Neurology